Why the study?
Does perioperative haemodynamic optimization and increasing oxygen delivery improve outcomes in critically ill and high-risk surgical patients?
Does perioperative haemodynamic optimization and increasing oxygen delivery improve outcomes in critically ill and high-risk surgical patients?
Therapies aimed at supranormal oxygen delivery do not improve outcomes in critically ill patients, highlighting the need for noninvasive resuscitation assessment and understanding mitochondrial dysfunction.
Answers are grounded in this paper and cite their sources.
No evidence supports post-ICU supranormal oxygen delivery targets; leaves open mitochondrial dysfunction mechanisms and noninvasive resuscitation strategies.
Perioperative haemodynamic optimization of high-risk surgical patients seems to be associated with a reduction in morbidity and mortality. There is, however, no evidence to support the use of treatment directed at achieving survivor values of oxygen delivery and consumption in critically ill patients after admission to intensive care. Mitochondrial dysfunction may be responsible for the inability of patients dying of sepsis to increase oxygen consumption and thus may explain why therapies directed at reducing mortality through increasing oxygen delivery have not been successful. In response to the recent controversy surrounding the risks versus benefits of pulmonary artery catheterization, current research is focusing on the development and evaluation of noninvasive methods to assess the adequacy of resuscitation.
No takes yet. Share an insight, caveat, or question.
Michelle Hayes (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: